Pluri Subsidiary Coffeesai and Instituto del Café de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico

Core Insights - Pluri Inc. has announced a collaboration with Instituto del Café de Chiapas to advance cell-based coffee manufacturing in Mexico, leveraging its subsidiary Coffeesai's technology [1][2][4] Group 1: Collaboration and Strategy - The collaboration aims to establish Chiapas as a hub for cell-based coffee innovation, combining biotechnology with local coffee traditions [2][4] - The partnership is structured around a three-phase roadmap to de-risk commercialization, starting with cell line development and moving towards pilot-scale biofarming and commercial-scale manufacturing [5][6] Group 2: Market Potential and Financial Outlook - The global coffee market exceeded $250 billion in 2024 and is projected to surpass $350 billion by 2030, indicating a significant opportunity for scalable production [5] - The collaboration is expected to create a revenue-generating model aligned with shareholder interests while transforming the future of coffee production [4][5] Group 3: Technological Innovation - Coffeesai will utilize Pluri's proprietary 3D cell expansion platform to develop sustainable coffee solutions that are resilient to climate change and market volatility [5][8] - The innovative process aims to eliminate the negative environmental impacts associated with traditional coffee farming, ensuring consistent quality and high yields [8]